Similar articles

Abstract: spinal muscular atrophy (SMA) is a disorder characterized by degeneration of lower motor neurons and occasionally bulbar motor neurons leading to progressive limb and trunk paralysis as well as muscular atrophy. Three types of SMA are recognized depending on the age of onset, the maximum muscular activity achieved, and survivorship: SMA1, SMA2, and SMA3. The survival of motor neuron (SMN) gene has been identified as an SMA determining gene, whereas the neuronal apoptosis inhibitory protein (NAIP) gene is considered to be a modifying factor of the severity of SMA. The main objective of this study was to analyze the deletion of SMN1 and NAIP genes in southern Chinese children with SMA. Here, polymerase chain reaction (PCR) combined with restriction fragment length polymorphism (RFLP) was performed to detect the deletion of both exon 7 and exon 8 of SMN1 and exon 5 of NAIP in 62 southern Chinese children with strongly suspected clinical symptoms of SMA. All the 32 SMA1 patients and 76% (13/17) of SMA2 patients showed homozygous deletions for exon 7 and exon 8, and all the 13 SMA3 patients showed single deletion of SMN1 exon 7 along with 24% (4/17) of SMA2 patients. Eleven out of 32 (34%) SMA1 patients showed NAIP deletion, and none of SMA2 and SMA3 patients was found to have NAIP deletion. The findings of homozygous deletions of exon 7 and/or exon 8 of SMN1 gene confirmed the diagnosis of SMA, and suggested that the deletion of SMN1 exon 7 is a major cause of SMA in southern Chinese children, and that the NAIP gene may be a modifying factor for disease severity of SMA1. The molecular diagnosis system based on PCR-RFLP analysis can conveniently be applied in the clinical testing, genetic counseling, prenatal diagnosis and preimplantation genetic diagnosis of SMA.

[1] Andreassi, C., Angelozzi, C., Tiziano, F.D., Vitali, T., de Vincenzi, E., Boninsegna, A., Villanova, M., Bertini, E., Pini, A., Neri, G., et al., 2004. Phenylbutyrate increases SMN expression in vitro: relevance for treatment of spinal muscular atrophy. Eur. J. Hum. Genet., 12(1):59-65.

[2] Azzouz, M., Le, T., Ralph, G.S., Walmsley, L., Monani, U.R., Lee, D.C., Wilkes, F., Mitrophanous, K.A., Kingsman, S.M., Burghes, A.H., et al., 2004. Lentivector-mediated SMN replacement in a mouse model of spinal muscular atrophy. J. Clin. Invest., 114(12):1726-1731.

[3] Battaglia, G., Princivalle, A., Forti, F., Lizier, C., Zeviani, M., 1997. Expression of the SMN gene, the spinal muscular atrophy determining gene, in the mammalian central nervous system. Hum. Mol. Genet., 6(11):1961-1971.

[4] Burnett, B.G., Sumner, C.J., 2008. Targeting splicing in spinal muscular atrophy. Ann. Neurol., 63(1):3-6.

[5] Campbell, L., Potter, A., Ignatius, J., Dubowitz, V., Davies, K., 1997. Genomic variation and gene conversion in spinal muscular atrophy: implications for disease process and clinical phenotype. Am. J. Hum. Genet., 61(1):40-50.

[6] Chan, V., Yip, B., Yam, I., Au, P., Lin, C.K., Wong, V., Chan, T.K., 2004. Carrier incidence for spinal muscular atrophy in southern Chinese. J. Neurol., 251(9):1089-1093.

[7] Chang, J.G., Jong, Y.J., Huang, J.M., Wang, W.S., Yang, T.Y., Chang, C.P., Chen, Y.J., Lin, S.P., 1995. Molecular basis of spinal muscular atrophy in Chinese. Am. J. Hum. Genet., 57(6):1503-1505.

[8] Chang, J.G., Jong, Y.J., Lin, S.P., Soong, B.W., Tsai, C.H., Yang, T.Y., Chang, C.P., Wang, W.S., 1997. Molecular analysis of survival motor neuron (SMN) and neuronal apoptosis inhibitory protein (NAIP) genes of spinal muscular atrophy patients and their parents. Hum. Genet., 100(5-6):577-581.

[9] Chen, K.L., Wang, Y.L., Rennert, H., Joshi, I., Mills, J.K., Leonard, D.G., Wilson, R.B., 1999. Duplications and de novo deletions of the SMNt gene demonstrated by fluorescence-based carrier testing for spinal muscular atrophy. Am. J. Med. Genet., 85(5):463-469.

[10] Chen, W.J., Wu, Z.Y., Lin, M.T., Su, J.F., Lin, Y., Murong, S.X., Wang, N., 2007. Molecular analysis and prenatal prediction of spinal muscular atrophy in Chinese patients by the combination of restriction fragment length polymorphism analysis, denaturing high-performance liquid chromatography, and linkage analysis. Arch. Neurol., 64(2):225-321.

[11] Chung, B., Wong, V., Ip, P., 2003. Prevalence of neuromuscular diseases in Chinese children: a study in southern China. J. Child Neurol., 18(3):217-219.

[12] Darras, B.T., Kang, P.B., 2007. Clinical trials in spinal muscular atrophy. Curr. Opin. Pediatr., 19(6):675-679.

[13] Dastur, R.S., Gaitonde, P.S., Khadilkar, S.V., Udani, V.P., Nadkarni, J.J., 2006. Correlation between deletion patterns of SMN and NAIP genes and the clinical features of spinal muscular atrophy in Indian patients. Neurol. India, 54(3):255-259.

[14] Frugier, T., Nicole, S., Cifuentes-Diaz, C, Melki, J., 2002. The molecular bases of spinal muscular atrophy. Curr. Opin. Genet. Dev., 12(3):294-298.

[15] Girardet, A., Fernandez, C., Claustres, M., 2008. Efficient strategies for preimplantation genetic diagnosis of spinal muscular atrophy. Fertil. Steril., 90(2):443.e7-443.e12.

[16] Gotz, R., Karch, C., Digby, M.R., Troppmair, J., Rapp, U.R., Sendtner, M., 2000. The neuronal apoptosis inhibitory protein suppresses neuronal differentiation and apoptosis in PC12 cells. Hum. Mol. Genet., 9(17):2479-2489.

[17] He, X.H., Zhang, X.N., Mao, W., Chen, H.P., Xu, L.R., Chen, H., He, X.L., Le, Y.P., 2004. A novel mutation of keratin 9 in a large Chinese family with epidermolysis palmoplantar keratoderma. Br. J. Dermatol., 150(4):647-651.

[18] Hsieh-Li, H.M., Chang, J.G., Jong, Y.J., Wu, M.H., Wang, N.M., Tsai, C.H., Li, H., 2000. A mouse model for spinal muscular atrophy. Nat. Genet., 24(1):66-70.

[19] Huang, C.H., Chang, Y.Y., Chen, C.H., Kuo, Y.S., Hwu, W.L., Gerdes, T., Ko, T.M., 2007. Copy number analysis of survival motor neuron genes by multiplex ligation-dependent probe amplification. Genet. Med., 9(4): 241-248.

[20] Lefebvre, S., Burglen, L., Reboullet, S., Clermont, O., Burlet, P., Viollet, L., Benichou, B., Cruaud, C., Millasseau, P., Zeviani, M., et al., 1995. Identification and characterization of a spinal muscular atrophy-determining gene. Cell, 80(1):155-165.

[21] Ogino, S., Wilson, R.B., 2004. Spinal muscular atrophy: molecular genetics and diagnosis. Exp. Rev. Mol. Diag., 4(1):15-29.

[22] Roy, N., Mahadevan, M.S., McLean, M., Shutler, G., Yaraghi, Z., Farahani, R., Baird, S., Besner-Johnston, A., Lefebvre, C., Kang, X., et al., 1995. The gene for neuronal apoptosis inhibitory protein is partially deleted in individuals with spinal muscular atrophy. Cell, 80(1):167-178.

[23] Schmutz, J., Martin, J., Terry, A., Couronne, O., Grimwood, J., Lowry, S., Gordon, L.A., Scott, D., Xie, G., Huang, W., et al., 2004. The DNA sequence and comparative analysis of human chromosome 5. Nature, 431(7006):268-274.

[24] Su, Y.N., Hung, C.C., Li, H., Lee, C.N., Cheng, W.F., Tsao, P.N., Chang, M.C., Yu, C.L., Hsieh, W.S., Lin, W.L., et al., 2005. Quantitative analysis of SMN1 and SMN2 genes based on DHPLC: a highly efficient and reliable carrier-screening test. Hum. Mutat., 25(5):460-467.

[25] Talbot, K., Rodrigues, N.R., Ignatius, J., Muntoni, F., Davies, K.E., 1997. Gene conversion at the SMN locus in autosomal recessive spinal muscular atrophy does not predict a mild phenotype. Neuromuscul. Disord., 7(3):198-201.

[26] Trülzsch, B., Davies, K., Wood, M., 2004. Survival of motor neuron gene downregulation by RNAi: towards a cell culture model of spinal muscular atrophy. Mol. Brain Res., 120(2):145-150.

[27] Tsai, C.H., Jong, Y.J., Hu, C.J., Chen, C.M., Shih, M.C., Chang, C.P., Chang, J.G., 2001. Molecular analysis of SMN, NAIP and P44 genes of SMA patients and their families. J. Neurol. Sci., 190(1-2):35-40.

[28] van der Steege, G., Grootscholten, P.M., van der Vlies, P., Draaijers, T.G., Osinga, J., Cobben, J.M., Scheffer, H., Buys, C.H., 1995. PCR based DNA test to confirm clinical diagnosis of autosomal recessive spinal muscular atrophy. Lancet, 345(8955):985-986.

[29] Watihayati, M.S., Zabidi-Hussin, A.M., Tang, T.H., Matsuo, M., Nishio, H., Zilfalil, B.A., 2007. Deletion analyses of SMN1 and NAIP genes in Malaysian spinal muscular atrophy patients. Pediatr. Int., 49(1):11-14.

[30] Wirth, B., 2000. An update of the mutation spectrum of the survival motor neuron gene (SMN1) in autosomal recessive spinal muscular atrophy (SMA). Hum. Mutat., 15(3):228-237.

[31] Wong, V., Chan, V., 2001. Molecular genetic study of a childhood form of spinal muscular atrophy. J. Child Neurol., 16(4):291-294.

[32] Yamashita, M., Nishio, H., Harada, Y., Matsuo, M., Yamamoto, T., 2004. Significant increase in the number of the SMN2 gene copies in an adult-onset Type III spinal muscular atrophy patient with homozygous deletion of the NAIP gene. Eur. Neurol., 52(2):101-106.

[33] Yu, Z.S., Zhou, B.L., Shui, Q.X., Shang, S.Q., 2001. Gene diagnosis of spinal muscular atrophy in Children. J. Zhejiang Univ. (Med. Sci.), 30(4):158-160 (in Chinese).